Competitiveness, Profitability and R/D Intensity: The Case of the Domestic Pharmaceutical Industry in Greece

Vasiliki Kounnou () and Dimitrios Kyrkilis ()
Additional contact information
Vasiliki Kounnou: University of Macedonia
Dimitrios Kyrkilis: University of Macedonia

A chapter in Business Performance and Financial Institutions in Europe, 2020, pp 47-55 from Springer

Abstract: Abstract Greek pharmaceutical industry has been emerged as one of the major drivers for the Greek manufacturing sector mostly from 2000 until 2011. The value-added of the industry in the overall economy is indicated through its impact on the gross value-added production, employment, exports, innovation and global competiveness. Greek pharmaceuticals firms have one of the highest shares of investment in innovation and R&D activities in the total Greek economy. The purpose of this study is to investigate the potential causal relationship between industry-level competitiveness, profitability and R/D intensity. Specific financial ratios have been selected for the regression analysis using a sample of Greek pharmaceutical firms with in-house Research and Development department. The period of the analysis has been defined between 2004 and 2015. According to the existing literature, it is expected that R/D intensity plays a significant role on the profitability for pharmaceutical firms.

Keywords: Greek pharmaceutical industry; R/D intensity; Competitiveness; Profitability; L1; L65 (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations: View citations in EconPapers (1)

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:conchp:978-3-030-57517-5_3

Ordering information: This item can be ordered from
http://www.springer.com/9783030575175

DOI: 10.1007/978-3-030-57517-5_3

Access Statistics for this chapter

More chapters in Contributions to Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().